SEC Form 4 · accession 0001209191-17-006519
Aravive, Inc. · ARAV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shane Ward
Officer — SVP and General Counsel
Period of report
Jan 27, 2017
Accepted (ET)
Jan 31, 2017 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 27, 2017 | A | 20,600 | $0.00 | A | 39,865 | D | |
| Common StockF2 | Jan 30, 2017 | S | 1,474 | $13.852 | D | 38,391 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $14.30 | Jan 27, 2017 | A | 46,200 | A | — | Jan 26, 2027 | Common Stock | 46,200 | 46,200 | D |
Explanation of responses
- F1Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the award vest on each of the first, second, third and fourth anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
- F2Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- F31/48th of the shares subject to the option become exercisable monthly measured from the date of grant.